Marshall Wace’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7M Buy
183,707
+176,329
+2,390% +$23.1M 0.02% 679
2025
Q4
$878K Buy
+7,378
New +$840K ﹤0.01% 2000
2025
Q2
Sell
-62,384
Closed -$7.98M 3018
2025
Q1
$7.98M Buy
+62,384
New +$8.97M 0.01% 860
2024
Q1
Sell
-14,732
Closed -$2.48M 2695
2023
Q4
$2.48M Buy
+14,732
New +$2.15M ﹤0.01% 1131
2021
Q2
Sell
-23,497
Closed -$3.1M 2938
2021
Q1
$3.1M Sell
23,497
-4,099
-15% -$539K 0.01% 1095
2020
Q4
$3.26M Sell
27,596
-46,473
-63% -$5.42M 0.02% 735
2020
Q3
$7.8M Buy
74,069
+33,015
+80% +$3.49M 0.05% 374
2020
Q2
$4.38M Buy
+41,054
New +$3.81M 0.03% 517

Other funds holding NOVT

Marshall Wace's NOVT Position: Q1 2026 in Review

Marshall Wace increased its Novanta (NOVT) stake by 2,390% in Q1 2026, buying an estimated $23.1M and bringing the position to 183,707 shares worth $21.7M. The position accounts for 0.02% of the portfolio, ranked #679.

Marshall Wace first reported a position in NOVT in Q2 2020 and has held it in 8 quarters since. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Marshall Wace held 183,707 shares of Novanta worth $21.7M as of Q1 2026.
  • Marshall Wace bought 176,329 Novanta shares in Q1 2026, an estimated $23.1M.
  • Novanta made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #679 holding.
  • Marshall Wace first reported a position in Novanta in Q2 2020 and has held it in 8 quarters since.
  • 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.